Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Transboundary and Emerging Diseases|September 28, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern SpainLeira Fernández-Bastit, Silvia Marfil, Edwards Pradenas, et al.
Scientific Reports|August 30, 2022
Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patientsSilvia Garcia-Cirera, Joan Calvet, Antoni Berenguer-Llergo, et al.
JCI Insight|February 19, 2026
Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulationJon Izquierdo-Pujol, Núria Pedreño-Lopez, Tetyana Pidkova, et al.
Communications Medicine|June 20, 2025
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infectionCarla Martín Pérez, Anna Ramírez-Morros, Alfons Jiménez, et al.
Iscience|March 31, 2023
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralizationEdwards Pradenas, Silvia Marfil, Víctor Urrea, et al.
Vaccines|August 29, 2024
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial ResultsMaría Jesús López Fernández, Silvia Narejos, Antoni Castro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
The Journal of Infection|January 2, 2025
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years laterRocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
Cell Reports|April 2, 2025
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemicLuis M Molinos-Albert, Rocío Rubio, Carla Martín-Pérez, et al.
Mbio|April 24, 2025
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 modelAnna Pons-Grífols, Ferran Tarrés-Freixas, Mònica Pérez, et al.
Pageof 6